Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Rises By 575.0%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the target of a large increase in short interest in September. As of September 30th, there was short interest totalling 2,700 shares, an increase of 575.0% from the September 15th total of 400 shares. Based on an average trading volume of 99,700 shares, the short-interest ratio is currently 0.0 days.

BriaCell Therapeutics Stock Performance

BriaCell Therapeutics stock opened at $0.35 on Friday. The company’s fifty day simple moving average is $0.26 and its 200-day simple moving average is $0.49. BriaCell Therapeutics has a 12 month low of $0.11 and a 12 month high of $2.60.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.